Many improvements have been made in fuel damage progression models of SCDAP after the Fukushima accident which are now being tested for the new reactor designs.
This polarization, as it is termed, may fuel disease progression or promote resolution of inflammation.
It will be insightful to decipher the key components regulating the metabolic machinery, in particular, those promoting the acquisition of permissive substrate utilization patterns that fuel disease progression and enable malignant transformation.
These observations might at least partially explain how the virus can form viral reservoirs in some target cells and thereby fuel the progression of the disease (Finzi et al. 1997; Pierson et al. 2000).
In addition, Nef could favor an homeostatic control of UPR and of oxidative stress observed during the acute phase of HIV infection and subsequently fuel the progression of the disease toward a chronic infection with the formation of cellular reservoirs of the virus.
Therefore, even though available evidence is not sufficient to favour one machinery over another for centrosome amplification in Nlp transgenic mice, by no means, the importance of deregulated centrosomal Nlp to fuel tumour progression is diminished, as supernumerary centrosomes always set a stage for CIN and tumourigenesis, regardless of their origins.
Similarly, we suggest that cancer chemotherapies that prevent hypoxia-induced- 3 and possibly traditional chemotherapy-stress-induced mutagenesis could both inhibit stress-induced mutations that fuel tumor progression and also inhibit mutation to resistance while a traditional chemotherapeutic agent does its job.
Here, we discuss the mechanics of the solid and fluid components of a tumor, with a focus on how they impede the transport of therapeutic agents and create an abnormal tumor microenvironment (TME) that fuels tumor progression and treatment resistance.
Indeed, such Shh-mediated metabolic reprogramming fuels tumor progression, in an E2F1- and FASN-dependent manner.
Therapy for advanced disease relies largely on chemotherapy and radiation therapy (reviewed in [ 2- 5]), both of which have significant host toxicity and themselves promote mutations, fueling disease progression and treatment resistance.
In prostate cancer, both the cancer cells and the adjacent CAFs will mediate oncogenic signals to fuel the cancer progression and metastasis [ 45, 46, 54].
